BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo.

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	PAVLASOVÁ Gabriela BORSKÝ Marek SVOBODOVÁ Veronika MUSILOVÁ Kateřina ČERNÁ Kateřina ŠEDA Václav NOVOTNÁ Jitka BRYCHTOVÁ Yvona DOUBEK Michael POSPÍŠILOVÁ Šárka MAYER Jiří MRÁZ Marek
Year of publication	2017
Type	Conference abstract
MU Faculty or unit	Central European Institute of Technology
Citation
Description	BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo., BCR signalling proficient chronic lymphocytic leukaemia cells are prone to rituximab mediated elimination in vivo.
Related projects:	MEDGENET - Medical genomics and epigenomics network CEITEC 2020 Vliv terapeutické inhibice BCR signalizace na genovou expresi u B buněčných malignit a její prognostický a prediktivní význam Nové přístupy ve výzkumu, diagnostice a terapii hematologických malignit IV Coding and Non-coding RNA Networks that Regulate B Cell Receptor Signalling: Implications for Combinatorial Therapy